Sentry LLC’s Bristol-Myers Squibb BMY Stock Holding History

Sentry LLC’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$995K	Buy	17,273 +101	+0.6%	+$5.8K	0.28%	46
2026 Q1	$1.04M	Sell	17,172 -896	-5%	-$52.2K	0.33%	42
2025 Q4	$975K	Hold	18,068	–	–	0.27%	45
2025 Q3	$815K	Hold	18,068	–	–	0.2%	50
2025 Q2	$836K	Hold	18,068	–	–	0.17%	51
2025 Q1	$1.1M	Buy	18,068 +901	+5%	+$52.5K	0.21%	38
2024 Q4	$971K	Sell	17,167 -901	-5%	-$50.3K	0.19%	42
2024 Q3	$935K	Buy	18,068 +37	+0.2%	+$1.74K	0.18%	43
2024 Q2	$749K	Sell	18,031 -101	-0.6%	-$4.52K	0.14%	51
2024 Q1	$983K	Sell	18,132 -183	-1%	-$9.32K	0.19%	43
2023 Q4	$940K	Hold	18,315	–	–	0.2%	40
2023 Q3	$1.06M	Hold	18,315	–	–	0.22%	35
2023 Q2	$1.17M	Hold	18,315	–	–	0.25%	33
2023 Q1	$1.27M	Buy	+18,315	New	+$1.29M	0.3%	29

Other funds holding BMY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Sentry LLC's BMY Position: Q2 2026 in Review

Sentry LLC increased its Bristol-Myers Squibb (BMY) stake by 0.59% in Q2 2026, buying an estimated $5.8K and bringing the position to 17,273 shares worth $995K. The position accounts for 0.28% of the portfolio, ranked #46.

Sentry LLC first reported a position in BMY in Q1 2023 and has held it in 14 quarters since. The position peaked at $1.27M in Q1 2023. 2,517 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

Sentry LLC held 17,273 shares of Bristol-Myers Squibb worth $995K as of Q2 2026.
Sentry LLC bought 101 Bristol-Myers Squibb shares in Q2 2026, an estimated $5.8K.
Bristol-Myers Squibb made up 0.28% of Sentry LLC's portfolio in Q2 2026, its #46 holding.
Sentry LLC first reported a position in Bristol-Myers Squibb in Q1 2023 and has held it in 14 quarters since.
Sentry LLC's Bristol-Myers Squibb position peaked at $1.27M in Q1 2023.
2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Sentry LLC's 13F filing for Q2 2026, filed 14 Aug 2026.